↓ Skip to main content

Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, July 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
38 Mendeley
Title
Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients
Published in
Journal of Cancer Research and Clinical Oncology, July 2019
DOI 10.1007/s00432-019-02983-3
Pubmed ID
Authors

Luca Nicosia, Rosario Mazzola, Michele Rigo, Vanessa Figlia, Niccolò Giaj-Levra, Giuseppe Napoli, Francesco Ricchetti, Stefanie Corradini, Ruggero Ruggieri, Filippo Alongi

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 13%
Student > Bachelor 4 11%
Student > Master 4 11%
Student > Ph. D. Student 4 11%
Other 3 8%
Other 7 18%
Unknown 11 29%
Readers by discipline Count As %
Medicine and Dentistry 15 39%
Nursing and Health Professions 3 8%
Engineering 2 5%
Agricultural and Biological Sciences 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 5%
Unknown 14 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2022.
All research outputs
#14,065,859
of 23,815,455 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#1,277
of 2,632 outputs
Outputs of similar age
#174,719
of 347,120 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#10
of 27 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,632 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,120 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.